Krystal Biotech, Inc. KRYS Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s other accrued liabilities?
- Krystal Biotech, Inc. (KRYS) reported other accrued liabilities of $3.18M in Q1 2026.
- How has Krystal Biotech, Inc.'s other accrued liabilities changed year-over-year?
- Krystal Biotech, Inc.'s other accrued liabilities decreased by 6.3% year-over-year, from $3.39M to $3.18M.
- What is the long-term trend for Krystal Biotech, Inc.'s other accrued liabilities?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s other accrued liabilities has grown at a 167.8% compound annual growth rate (CAGR), from $26K to $3.58M.